Risk of incident and recurrent nephrolithiasis following initiation of sodium-glucose co-transporter-2 inhibitors and glucagon-like peptide 1 receptor agonists among patients with type 2 diabetes in Denmark, Norway, the Netherlands, the United Kingdom and Taiwan
- Resource Type
- Authors
- Lund, Christian; Pottegård, Anton; Karlstad, Øystein; Ruiz, Paz; Gulseth, Hanne; Abtahi, Shahab; Klungel, Olaf; Souverein, Patrick; Burden, Andrea; de la Torre, Adrian; Hsieh, Miyuki; Lai, Edward
- Source
- Subject
- Medicine and Health Sciences
- Language
Active comparator new-user cohort study and meta-analysis comparing the rate of incident and recurrent nephrolithiasis among initiatiors of sodium-glucose co-transporter 2 inhibitors to rates among initiators glucagon-like peptide 1 receptor agonists.